Frequently Asked Questions About CMV Management
Listen to Atul Humar, MD, FRCP(C); Hannah Imlay, MD, MS; and Raymund Razonable, MD, discuss frequently asked questions about CMV management in solid organ transplantation recipients.
Decera Clinical Education Infectious Disease Podcast · Hannah Imlay MD MS, Raymund Razonable MD, Atul Humar MD FRCP(C)
Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode, Atul Humar, MD, FRCP(C); Hannah Imlay, MD, MS; and Raymund Razonable, MD, discuss cytomegalovirus (CMV) management strategies in solid organ transplantation recipients, including:
- Evaluation of current data on CMV prevention in liver transplant recipients
- Practical considerations for switching an institution’s antiviral therapy of choice for primary prophylaxis
- Barrier of resistance to antiviral therapies
- Factors to consider when deciding CMV treatment duration
- Use of lymphocyte count to assess CMV cell–mediated immunity
Program Director:
Atul Humar, MD, FRCP(C)
Professor of Medicine
University of Toronto
Director, Ajmera Transplant Centre
University Health Network
R. Fraser Elliott Chair in Transplantation
Director University of Toronto Transplant Institute
Toronto, Ontario, Canada
Faculty:
Hannah Imlay, MD, MS
Assistant Professor of Medicine
Department of Internal Medicine, Division of Infectious Diseases
University of Utah
Salt Lake City, Utah
Raymund Razonable, MD
Professor of Medicine
Program Director, Infectious Diseases Fellowship
Vice Chair, Division of Infectious Diseases
Mayo Clinic
Rochester, Minnesota
Content based on a CME program supported by an educational grant from Merck & Co., Inc., Rahway, NJ, USA.
Follow along with a downloadable slideset at:
https://bit.ly/476v2wI
Link to full program:
https://bit.ly/47lNK2K
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.